Ledger.Open graph →
SEC Form D · filed March 21, 2016

EYEGATE PHARMACEUTICALS INC

Offering
$2.6M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Stephen From · Waltham, MAExec · DirectorThomas F. Balland · Waltham, MADirectorPraveen F. Tyle · Waltham, MADirectorPaul Chaney · Waltham, MADirectorBernard E. Malfroy-Camine · Waltham, MADirectorThomas E. Hancock · Waltham, MADirectorMorton F. Goldberg · Waltham, MADirectorMounia E. Chaoui · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorThomas F. Balland · Waltham, MADirectorPraveen F. Tyle · Waltham, MADirectorMounia E. Chaoui · Waltham, MADirectorPaul Chaney · Melville, NYDirectorBernard E. Malfroy-Camine · Waltham, MADirectorThomas E. Hancock · Waltham, MADirectorMorton F. Goldberg · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗